Patients should discuss with their healthcare provider how retatrutide fits into their overall treatment plan, taking into account their medical history, current medications, and the potential for greater average weight loss compared to other weight loss medications
Clinical trials show patients on semaglutide or tirzepatide report feeling satisfied with substantially smaller meal portions
These may include blood sugar markers, insulin resistance markers, thyroid function, liver enzymes, kidney function, cholesterol, triglycerides, inflammation markers, hormone-related testing, or nutrient status when appropriate
Some patients report modest weight changes of 1 to 3 pounds, likely related to reduced inflammation-driven fluid retention rather than fat loss
While genetics do not determine your exact weight loss percentage, they help your PlexusDx provider choose the right compound and dosing strategy to maximize your personal results